Guideline on antiplatelet and anticoagulation management in cardiac surgery.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Cardio-Thoracic Surgery

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejcts.2008.02.024PMID 18375137
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surgical management of valvular heart disease

  2010influential reference
• Evidence-Based Medicine: How to Practice and Teach It

  2010cited by this paper
• Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology

  2007cited by this paper
• Drug therapy: Prevention and treatment of major blood loss

  2007cited by this paper
• Antithrombotic therapy following bioprosthetic aortic valve replacement.

  2007cited by this paper
• Prevention and treatment of major blood loss.

  2007cited by this paper
• Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery

  2007influential reference
• Antiplatelet therapy after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk.

  2007cited by this paper
• Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.

  2007cited by this paper
• Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.

  2007cited by this paper
• Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.

  2007cited by this paper
• Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

  2007cited by this paper
• Effect of topical tranexamic acid in open heart surgery

  2006cited by this paper
• Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.

  2006cited by this paper
• Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery?

  2006cited by this paper
• Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.

  2006cited by this paper
• Should high risk patients receive clopidogrel as well as aspirin post coronary arterial bypass grafting?

  2006cited by this paper
• Best evidence topic - Cardiac general Should patients post-cardiac surgery be given low molecular weight heparin for deep vein thrombosis prophylaxis?

  2006cited by this paper
• Guidelines on oral anticoagulation (warfarin): third edition – 2005 update

  2006cited by this paper
• Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials

  2006cited by this paper
• Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery: Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae?

  2006cited by this paper
• The risk associated with aprotinin in cardiac surgery.

  2006cited by this paper
• Early postoperative anticoagulation after mechanical valve replacement: a systematic review.

  2006cited by this paper
• Is short-term anticoagulation necessary after mitral valve repair?

  2006influential reference
• Should warfarin be routinely prescribed for the first three months after a bioprosthetic valve replacement?

  2006cited by this paper
• Aprotinin in cardiac surgery

  2006cited by this paper
• Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?

  2006cited by this paper
• Best evidence topic - Cardiac general Should clopidogrel be stopped prior to urgent cardiac surgery?

  2006cited by this paper
• Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery.

  2006cited by this paper
• Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis

  2005cited by this paper
• Can the use of thromboelastography predict and decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery?

  2005cited by this paper
• An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.

  2005influential reference
• Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Surgery and Effects of Antiplatelet Therapy

  2005cited by this paper
• Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?

  2005cited by this paper
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction With ST-Segment Elevation

  2005cited by this paper
• JBS 2: Joint British Societies9 guidelines on prevention of cardiovascular disease in clinical practice

  2005cited by this paper
• Prophylaxis and treatment of deep vein thrombosis in general surgery.

  2005cited by this paper
• The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]

  2005cited by this paper
• In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution.

  2005cited by this paper
• Antithrombotic therapy during percutaneous coronary intervention

  2005cited by this paper
• Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review

  2005cited by this paper
• Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery.

  2005cited by this paper
• Recommendations for the management of patients after heart valve surgery.

  2005cited by this paper
• Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?

  2005cited by this paper
• Atrial fibrillation at discharge from the hospital in patients undergoing mitral valve repair.

  2005cited by this paper
• Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score–matched case‐control analysis

  2005cited by this paper
• Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

  2005cited by this paper
• Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study.

  2005cited by this paper
• Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery.

  2005cited by this paper
• JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

  2005cited by this paper
• Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

  2005cited by this paper
• Recombinant activated factor VII for refractory bleeding after cardiac surgery—A retrospective analysis of safety and efficacy

  2005cited by this paper
• Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma

  2005cited by this paper
• Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.

  2005cited by this paper
• [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].

  2005cited by this paper
• Clopidogrel and bleeding after coronary artery bypass graft surgery.

  2005cited by this paper
• Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention.

  2004cited by this paper
• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

  2004cited by this paper
• Deep vein thrombosis among patients entering cardiac rehabilitation after coronary artery bypass surgery.

  2004cited by this paper
• Is addition of anti-platelet therapy to warfarin beneficial to patients with prosthetic heart valves?

  2004influential reference
• Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery

  2004cited by this paper
• Surgical management of valvular heart disease 2004.

  2004cited by this paper
• Recombinant activated factor VII in cardiac surgery

  2004cited by this paper
• Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies

  2004cited by this paper
• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

  2004cited by this paper
• Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial bioprosthesis.

  2004cited by this paper
• Comparing Warfarin With Aspirin After Biological Aortic Valve Replacement: A Prospective Study

  2004cited by this paper
• Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage

  2004cited by this paper
• Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery.

  2004cited by this paper
• Impact of clopidogrel in coronary artery bypass grafting.

  2004cited by this paper
• Best evidence topic - Cardiac general Does the use of topical tranexamic acid in cardiac surgery reduce the incidence of post-operative mediastinal bleeding?

  2004cited by this paper
• Comparison of heparin administration using the Rapidpoint Coag and Hepcon HMS.

  2004cited by this paper
• Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding.

  2004cited by this paper
• Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Safety profile of recombinant factor VIIa.

  2004cited by this paper
• Does prophylactic tranexamic acid safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery?

  2004cited by this paper
• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

  2004cited by this paper
• Does use of aprotinin in coronary artery bypass graft surgery affect graft patency?

  2004cited by this paper
• Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Is clopidogrel beneficial following coronary bypass surgery?

  2004influential reference
• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

  2004cited by this paper
• Does aspirin 6 h after coronary artery bypass grafting optimise graft patency?

  2003cited by this paper
• In patients post cardiac surgery do high doses of protamine cause increased bleeding?

  2003cited by this paper
• Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting time

  2003cited by this paper
• What is the optimal dose of aspirin after discharge following coronary bypass surgery.

  2003influential reference
• Towards evidence-based medicine in cardiothoracic surgery: best BETS.

  2003cited by this paper
• Indirect comparison meta-analysis of aspirin therapy after coronary surgery

  2003cited by this paper
• Near‐patient testing of haemostasis in the operating theatre: an approach to appropriate use of blood in surgery

  2003cited by this paper
• Long-term results of mitral valve replacement: biological xenograft versus mechanical valves

  2003cited by this paper
• Aspirin and mortality from coronary bypass surgery.

  2002cited by this paper
• Hemostatic Activation and Inflammatory Response during Cardiopulmonary Bypass: Impact of Heparin Management

  2002cited by this paper
• Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography.

  2002cited by this paper
• Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass.

  2002cited by this paper
• The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting.

  2002cited by this paper
• Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery.

  2002cited by this paper
• Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting

  2002cited by this paper
• Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

  2001cited by this paper

• Beyond the incision: assessing bleeding risks in early aspirin administration post coronary artery bypass grafting

  2025cites this paper
• Redefining haemostasis: Role of rotational thromboelastometry in critical care settings

  2025cites this paper
• Venous Thromboembolism after Coronary Artery Bypass Increases Healthcare Costs: A Propensity Score Matched Analysis.

  2025cites this paper
• Correlation Between Blood Coagulation Profile and Viscosity: Clinical Laboratory Observational Study

  2025cites this paper
• Post-procedural anticoagulation enhances cognitive function and reduces stroke risk in atrial fibrillation patients after left atrial appendage occlusion.

  2025cites this paper
• Innovative strategies in coagulation management for cardiothoracic surgery: a narrative review of pharmacological and nonpharmacological approaches

  2025cites this paper
• Antithrombotic therapy after cardiac valve surgery: prospective real-world data of Class II guidelines application and outcomes from the EURObservational Research Programme Valvular Heart Disease II survey

  2025cites this paper
• Perioperative Care after Surgical Correction of Congenital Heart Defects in Premature Infants

  2025cites this paper
• Prevalence and Predictors of Venous Thromboembolism Following Coronary Bypass Surgery

  2025cites this paper
• Liver Transplantation Using Allografts With Hepatic Artery Injury During Procurement: A Propensity Score‐Matched Analysis of Outcomes

  2025cites this paper
• Perioperative patient blood management in one-stage bilateral calcar-guided short stem hip arthroplasty

  2025cites this paper
• Analysis of Risk Factors for Heparin Resistance During Cardiac Surgery: Does Antithrombin Deficiency Cause Heparin Resistance?

  2025cites this paper
• Prolonged Stay in ICU after Cardiac Surgery: Challenges –A Review

  2024cites this paper
• Examining the controversies in venous thromboembolism prophylaxis for vascular surgery patients: A critical review.

  2024cites this paper
• Dual Antiplatelet Therapy After Elective Coronary Artery Bypass Graft and Its Impact on Clinical Outcomes

  2024cites this paper
• Different antithrombotic strategies after coronary artery bypass grafting to prevent adverse events: a retrospective analysis

  2024cites this paper
• Anticoagulation for cardiopulmonary bypass: part one.

  2023cites this paper
• Hemostatic disorders in patients with infective endocarditis undergoing urgent surgical valve replacement - Rethinking current beliefs.

  2023cites this paper
• The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study

  2023cites this paper
• Outcome and management of decompressive hemicraniectomy in malignant hemispheric stroke following cardiothoracic surgery

  2023cites this paper
• Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery

  2022cites this paper
• Thromboembolic events and major bleeding with warfarin, non-vitamin K antagonist oral anticoagulants or antiplatelets following mitral valve repair: A systematic review and meta-analysis

  2022cites this paper
• Should nasogastric tube be used routinely in patients undergoing cardiac surgery? A narrative review

  2022cites this paper
• Which antithrombotic strategy provides the best outcomes after mitral valve repair in patients who remain in sinus rhythm?

  2022cites this paper
• Off - pump coronary artery bypass grafting on patients with preoperative dual antiplatelets: our centre experience

  2022cites this paper
• Manejo anestésico en la cirugía de reparación valvular mitral

  2022cites this paper
• Deep vein thrombosis and pulmonary embolism after heart transplantation

  2022cites this paper
• Guidelines for enhanced recovery after cardiac surgery. Consensus document of Spanish Societies of Anesthesia (SEDAR), Cardiovascular Surgery (SECCE) and Perfusionists (AEP).

  2021cites this paper
• Secondary Prevention Medications Post Coronary Artery Bypass Grafting Surgery—A Literature Review

  2021cites this paper
• Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST

  2021cites this paper
• The Association between Glycosylated Hemoglobin Level and Platelets Reactivity in Patients with Diabetes Mellitus Undergoing Elective Coronary Artery Bypass Grafting

  2021cites this paper
• Thrombocytagátló és antikoagulációs terápia a szívsebészetben napjainkban.

  2021cites this paper
• New and Off-Label Uses of Tranexamic Acid.

  2021cites this paper
• Personalized Medicine in Anesthesia, Pain and Perioperative Medicine

  2021cites this paper
• Initiation of and persistence with P2Y12 inhibitors in patients with myocardial infarction according to revascularization strategy: a nationwide study.

  2021cites this paper
• The impact of antiplatelet and antithrombotic regimen after TAVI

  2021cites this paper
• Cardiac Surgery in Patients With Blood Disorders.

  2021cites this paper
• Anticoagulation and Transfusion Management During Neonatal and Pediatric Extracorporeal Membrane Oxygenation: A Survey of Medical Directors in the United States*

  2021cites this paper
• Personalized Cardiac Anesthesia

  2020cites this paper
• Anticoagulation After Isolated Mitral Valve Repair: A Systematic Review and Meta-Analysis of Clinical Outcomes.

  2020cites this paper
• Effect of antithrombin in fresh frozen plasma on hemostasis after cardiopulmonary bypass surgery

  2020cites this paper
• 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2020cites this paper
• Thromboelastographic Evaluation in Patients with Severe Sepsis or Septic Shock: A Preliminary Analysis

  2020cites this paper
• The Perioperative Management of the Patient with Chronic Kidney Disease

  2020cites this paper
• Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO

  2020cites this paper
• Preoperative Clopidogrel Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations

  2020cites this paper
• Protamine stimulates platelet aggregation in vitro with activation of the fibrinogen receptor and alpha-granule release, but impairs secondary activation via ADP and thrombin receptors

  2020cites this paper
• Venous thromboembolism prophylaxis after minimally-invasive cardiac surgery: harm or benefit?

  2020cites this paper
• Guidelines for enhanced recovery after cardiac surgery. Consensus document of Spanish Societies of Anesthesia (SEDAR), Cardiovascular Surgery (SECCE) and Perfusionists (AEP)

  2020cites this paper
• How to Handle Arterial Conduits in Liver Transplantation? Evidence From the First Multicenter Risk Analysis

  2020influential citation
• Vía clínica de recuperación intensificada en cirugía cardiaca. Documento de consenso de la Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR), la Sociedad Española de Cirugía Cardiovascular y Endovascular (SECCE) y la Asociación Española de Perfusionistas (AEP)

  2020cites this paper
• Effect of bivalirudin on neointimal hyperplasia and endothelial proliferation in rabbit

  2020cites this paper
• Dual Antiplatelet Therapy before Coronary Artery Bypass Grafting; a Systematic Review and Meta-Analysis

  2020cites this paper
• Three Cases of Anaphylaxis to Protamine: Management of Anticoagulation Reversal.

  2019cites this paper
• Association of Acute Venous Thromboembolism With In‐Hospital Outcomes of Coronary Artery Bypass Graft Surgery

  2019cites this paper
• A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury.

  2019cites this paper
• Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis.

  2019cites this paper
• Anesthetic Challenges in Minimally Invasive Cardiac Surgery

  2019cites this paper
• Aalborg Universitet Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis

  2019cites this paper
• P2Y12 Antagonists

  2019cites this paper
• BloodSurf 2017: News from the blood-biomaterial frontier.

  2019cites this paper
• Perioperative Medication Management in Adult Cardiac Surgery: The 2017 European Association for Cardio-Thoracic Surgery Guidelines.

  2019cites this paper
• Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations.

  2019cites this paper
• Benefits may not outweigh risks of low molecular weight heparin (LMWH) in early postoperative thromboprophylaxis following minimally invasive cardiac surgery: a propensity score-matched analysis.

  2019cites this paper
• Postoperative Care After Cardiac Surgery

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018influential citation
• The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines—Anticoagulation During Cardiopulmonary Bypass

  2018cites this paper
• STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass.

  2018cites this paper
• The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass.

  2018cites this paper
• Higher Preoperative Plasma Thrombin Potential in Patients Undergoing Surgery for Aortic Stenosis Compared to Surgery for Stable Coronary Artery Disease

  2018cites this paper
• Manejo del tratamiento antitrombótico en cirugía cardiovascular: puntualización sobre el Documento de Consenso acerca del manejo perioperatorio y periprocedimiento del tratamiento antitrombótico

  2018cites this paper
• Chapter 37 – Principles of Cardiovascular Surgery

  2018cites this paper
• Infected symptomatic carotid artery atheroma concurrent with bacterial endocarditis

  2018cites this paper
• 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.

  2018cites this paper
• Manejo del tratamiento antitrombótico en cirugía cardiovascular: puntualización sobre el Documento de Consenso acerca del manejo perioperatorio y periprocedimiento del tratamiento antitrombótico

  2018cites this paper
• Recommendation for Outpatient Follow-Up After Aortic Valve Surgery

  2018cites this paper
• Effectiveness of adherence to a preoperative antiplatelet and anticoagulation cessation protocol in cardiac surgery.

  2018cites this paper
• Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?

  2018cites this paper
• Early myocardial surgical revascularization after ST-segment elevation myocardial infarction in multivessel coronary disease: bridge therapy is the solution?

  2018cites this paper
• Care for the Postoperative Cardiac Surgery Patient

  2018cites this paper
• Biočina B. (2015) Development of a concept for a personalized approach in the perioperative antiplatelet therapy administration/discontinuation management based on multiple electrode aggregometry in patients undergoing coronary artery

  2017influential citation
• European guidelines on perioperative venous thromboembolism prophylaxis: Cardiovascular and thoracic surgery.

  2017cites this paper
• Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital.

  2017cites this paper
• Coagulopathy In and Outside the Intensive Care Unit.

  2017cites this paper
• Perioperative Aspirin in Cardiac and Noncardiac Surgery.

  2017cites this paper
• Frequency of Deep Vein Thrombosis and/or Pulmonary Embolism After Coronary Artery Bypass Grafting Investigation Regardless of Clinical Suspicion.

  2017cites this paper
• Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis

  2017cites this paper
• Preoperative aspirin use and acute kidney injury after cardiac surgery: A propensity-score matched observational study

  2017cites this paper
• Risks and benefits of giving early Aspirin within 6 hours of CABG: A retrospective analysis

  2017cites this paper
• Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.

  2017cites this paper
• Antiplatelet therapy with CABG: chaos in the Netherlands

  2017cites this paper
• Early Aspirin administration post Coronary Artery Bypass Graft Surgery – Changing hospital culture through a two-cycled audit

  2017cites this paper
• Results of Surgical Managment of Primary Mitral Regurgitation in a Single-center Study

  2017cites this paper
• Practice Guidelines : Anticoagulation During Cardiopulmonary Bypass

  2017cites this paper
• Storage time of intraoperative transfused allogeneic red blood cells is not associated with new-onset postoperative atrial fibrillation in cardiac surgery

  2017cites this paper
• Management and Prevention of Saphenous Vein Graft Failure: A Review

  2017cites this paper
• Postoperative Bleeding After Change in Heparin Supplier: A Cardiothoracic Center Experience.

  2017cites this paper
• Thromboelastrography (TEG) Is Still Relevant in the 21st Century as a Point-of-Care Test for Monitoring Coagulation Status in the Cardiac Surgical Suite

  2017cites this paper
• 7.29 Vascular Grafts

  2017cites this paper
• Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.

  2016cites this paper